Effects of Personalised Exercise Rehabilitation FOR people with Multimorbidity and cardiac or pulmonary disease: the PERFORM-CPR trial.

Not Applicable

Not yet recruiting

• Conditions: Post myocardial infarction; Post cardiac revascularization; Stable angina; Heart failure; Chronic Obstructive Pulmonary Disease (COPD); Bronchiectasis; Asthma; Cancer; Interstitial lung disease; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12624001191583
• Lead Sponsor: Monash University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2024-09-30
• Last Update Posted: 30 September 2024

Recruitment & Eligibility

• Status: Not yet recruiting
• Sex: All
• Target Recruitment: 604

Inclusion Criteria

Adults aged 18 yearsAble and willing to provide informed consentIndependently ambulant (including the use of walking aids) Scores in the modified Medical Research Council dyspnoea scale => 2 OR New York Heart Association classification => II Cardiac or pulmonary chronic conditions such as post myocardial infarction, post cardiac revascularization, stable angina, heart failure, COPD, bronchiectasis, and asthmaIn addition, one of the following long-term health conditions: - arthritis- atrial fibrillation- cancer- chronic kidney disease- connective tissue disease (pain)- mild dementia (less than or equal to four errors in the Short Portable Mental Status Questionnaire)- depression- diabetes mellitus- hypertension,- long-COVID- multiple sclerosis- osteoporosis- painful condition due to chronic musculoskeletal conditions: osteoarthritis (hand, hip, and knee), chronic back and neck pain, shoulder impingement, and rotator cuff degeneration- Parkinson’s disease- peripheral vascular disease- polycystic ovarian syndrome- psychoactive substance misuse- stroke or transient ischaemic attack. Patients can also have one of the following conditions from the list below:- anorexia nervosa or bulimia- anxiety- atrial fibrillation- chronic fatigue syndrome- chronic liver disease- chronic sinusitis- diverticular disease- endometriosis, epilepsy- glaucoma- inflammatory bowel disease- irritable bowel syndrome- Meniere’s disease- migraines- pernicious anaemia- prostate disorders- psoriasis or eczema- schizophrenia or bipolar affective disorder- thyroid disease- treated constipation- treated dyspepsia- viral hepatitis

Exclusion Criteria

Unable to communicate in EnglishKnown contraindications to exercise (as defined by the American College of Sports Medicine, Ed. 2021): unstable cardiac disease, current fever, and significant aortic aneurysm (more than 5.5 cm).Unable to attend in-person training sessions Participation in a exercised rehabilitation programme in the last 6 months Unstable psychiatric disorder that limits or disrupts group based interventions Active malignancy (on chemotherapy/radiotherapy/planned urgent surgery) with a prognosis of less than 12 months survivalPregnancyLiving in a residential aged care facilityUnsafe to exercise in a group without 1:1 supervision (e.g. significant risk of falls)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Health-related quality of life [EQ-5D-5L. Baseline and end intervention (3 months)]